Analysts expect CollPlant Biotechnologies to report an earnings per share (EPS) of $-0.37. Investors in CollPlant Biotechnologies are eagerly awaiting the company's announcement, hoping for news of ...

Fantastical has always made creating new calendar events easy with natural language input within the app. Now Fantastical is ...

RadNet's acquisition of iCAD promises innovation synergies and minimal risks. See why I recommend longing iCAD and shorting 0 ...

Including an inaugural capsule with Los Angeles-based skate brand Sci-Fi Fantasy and new inline merchandise from graphic tees ...